cyclopentane has been researched along with vasoactive intestinal peptide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dittrich, J; Encke, A; Kather, H; Kommerell, B; Simon, B | 1 |
Ausiello, DA; de Almeida, JB; Lencer, WI; Madara, JL; Moe, S; Stow, JL | 1 |
2 other study(ies) available for cyclopentane and vasoactive intestinal peptide
Article | Year |
---|---|
Inhibition of human colonic adenylate cyclase by RMI 12330 A.
Topics: Adenylyl Cyclases; Animals; Colon; Cyclopentanes; Dose-Response Relationship, Drug; Enzyme Repression; Humans; Imines; Intestinal Mucosa; Intestinal Secretions; Prostaglandins E; Prostaglandins E, Synthetic; Rats; Vasoactive Intestinal Peptide | 1978 |
Entry of cholera toxin into polarized human intestinal epithelial cells. Identification of an early brefeldin A sensitive event required for A1-peptide generation.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Analysis of Variance; Biological Transport; Brefeldin A; Cell Line; Cell Membrane; Chlorides; Cholera Toxin; Cyclic AMP-Dependent Protein Kinases; Cyclopentanes; Dose-Response Relationship, Drug; Humans; Intestinal Mucosa; Kinetics; Models, Biological; NAD; Protein Binding; Protein Synthesis Inhibitors; Temperature; Time Factors; Vasoactive Intestinal Peptide | 1993 |